Fastin (Phentermine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 26, 2017 Category: Drugs & Pharmacology Source Type: news
Bucks company's weight-reduction pill gets FDA approval
The Food and Drug Administration has approved a Bucks County company ’s prescription weight reduction medicine, a low-dose and low-cost formulation of phentermine hydrochloride. Here are the details:
Company: KVK Tech, a Newtown-based manufacturer of prescription and over-the-counter medicines.
Product: Lomaira
Approved as: An adjunct therapy for use over a shor t period of time for weight reduction in adults with an initial body mass index of 30 or more, or a body mass index of 27 or more with… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 27, 2016 Category: Pharmaceuticals Authors: John George Source Type: news
Bucks company's weight-reduction pill gets FDA approval
The Food and Drug Administration has approved a Bucks County company ’s prescription weight reduction medicine, a low-dose and low-cost formulation of phentermine hydrochloride. Here are the details:
Company: KVK Tech, a Newtown-based manufacturer of prescription and over-the-counter medicines.
Product: Lomaira
Approved as: An adjunct therapy for use over a shor t period of time for weight reduction in adults with an initial body mass index of 30 or more, or a body mass index of 27 or more with… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 27, 2016 Category: Biotechnology Authors: John George Source Type: news
KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction
NEWTOWN, Pa., Sept. 20, 2016 -- (Healthcare Sales & Marketing Network) -- KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira (phentermine hydrochloride USP) 8 mg tablets CIV, a low-cost, low-dose prescrip... Biopharmaceuticals, FDA KVK Tech, Lomaira, phentermine, anorectic, obesity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2016 Category: Pharmaceuticals Source Type: news
KVK Tech Announces FDA-Approval of Lomaira (phentermine hydrochloride USP) for Weight Reduction
NEWTOWN, Pa., Sept. 20, 2016 /PRNewswire/ -- KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira (phentermine hydrochloride USP) 8 mg tablets CIV, a low-cost, low-dose prescription medicine used for a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 20, 2016 Category: Drugs & Pharmacology Source Type: news
Weight Loss Pills And Products Don't Work And Aren't Safe
Our ancestors lived in a feast or famine world. When you don't know where your next meal is coming from, or when it will arrive, the smart play is to pig out every time food is available. Our genes are programmed to extract as much energy as possible from what we eat and to store any extra energy in fat reservoirs, available in reserve for future famines.
These deeply ingrained genetic tendencies worked great in the austere world of our ancestors, but are a disaster in our current world of refrigerators, ubiquitous fast food joints and milk shakes.
Only one third of Americans are now able to maintain a normal weight; one ...
Source: Science - The Huffington Post - September 5, 2016 Category: Science Source Type: news
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - VIVUS, Inc. (VVUS) today announced that the United States District Court for the District of New Jersey has issued a claim construction (Markman) ruling governing patent litigation brought by VIVU... Biopharmaceuticals, Generics, LitigationVIVUS, Actavis Laboratories, Teva Pharmaceutical, Qsymia, phentermine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2016 Category: Pharmaceuticals Source Type: news
Phentermine-topiramate tops competition for long-term weight loss
SAN DIEGO – Phentermine-topiramate was the most effective long-term weight loss drug, based on findings from a network meta-analysis from the University of California, San Diego.
The investigators... (Source: Family Practice News)
Source: Family Practice News - June 20, 2016 Category: Primary Care Source Type: news
Phentermine-topiramate tops competition for long-term weight loss
SAN DIEGO – Phentermine-topiramate was the most effective long-term weight loss drug, based on findings from a network meta-analysis from the University of California, San Diego.
The investigators... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 20, 2016 Category: Endocrinology Source Type: news
SGLT2 Inhibitor Adds to Weight Loss With Phentermine (CME/CE)
(MedPage Today) -- Canagliflozin may have synergistic effect with standard obesity drug (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 15, 2016 Category: Cardiology Source Type: news
Two Weight-Loss Drugs Have Highest Odds for 5% ReductionTwo Weight-Loss Drugs Have Highest Odds for 5% Reduction
Phentermine-topiramate and liraglutide were most likely among five obesity drugs approved by the FDA for long-term use to help people achieve a 5% weight loss over a year, a meta-analysis shows. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 15, 2016 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
5 weight loss drugs that actually work in the US
Scientists at the University of California found of the drugs - orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide - the last two, marketed as Qsymia, Saxenda and Victoza were most effective. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2016 Category: Consumer Health News Source Type: news
Experts rated weight-loss drugs and Qsymia came out on top
In the diet-medication sweepstakes, we have a winner. While all five drugs approved by the Food & Drug Administration for weight loss best a placebo in helping patients lose weight, a drug known commercially as Qsymia — a combination of the drugs phentermine and topiramate — most consistently prompted... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - June 14, 2016 Category: Science Authors: Melissa Healy Source Type: news
Revealed... the 5 weight loss drugs that ACTUALLY work - helping obese people shed up to 20lbs in a year
Scientists at the University of California found of the drugs - orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide - the last two, marketed as Qsymia, Saxenda and Victoza were most effective. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2016 Category: Consumer Health News Source Type: news
Study compares effectiveness of weight-loss drugs
In an analysis that included nearly 30,000 overweight or obese adults, compared with placebo, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide were each associated with achieving at least 5 percent weight loss at 52 weeks, and phentermine-topiramate and liraglutide were associated with the highest odds of achieving at least 5 percent weight loss, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 14, 2016 Category: Science Source Type: news
